Clinical trials: First-ever Ischemic Stroke
First-ever Ischemic Stroke, Cognitive Performance
Post-stroke Cognitive Impairment
Present study aims to track the post-stroke cognitive trajectories and to investigate its inter-individual variability.
- Trial name
- CogStroke (NCT05653141)
- Where
- Switzerland
- Volunteers
- 600 people
- Sponsor
- Roza Umarova
Stroke
Evaluation of the Effect of Dextro-Amphetamin Added to Physiotherapy in Patients After Stroke
The aim of the study is to evaluate the effect of Dextro-amphetamin added to physiotherapy on motor recovery in patients after stroke. The study is a double-blinded placebo-controlled randomised controlled trial.
- Trial name
- NCT00572767
- Testing
- Dextro-Amphetamin, Glucose
- Where
- Switzerland
- Volunteers
- 16 people
- Sponsor
- Reha Rheinfelden
Stroke, Cardiovascular Diseases
MIDNOR-STROKE- a Long Term Follow-up Study of Patients With First Ever Ischemic Stroke in Central Norway
Annually 13000 Norwegians experience an ischemic stroke. The number of stroke is anticipated to increase with 50% within 2030 due to a growing number of elderly.
- Conditions
- Stroke, Cardiovascular Diseases, Cardiovascular Risk Factor, Brain Ischemia
- Trial name
- NCT03962127
- Testing
- no intervention
- Where
- 8 sites in Norway
- Volunteers
- 800 people
- Sponsor
- Norwegian University of Science and Technology
Ischemic Stroke
Smoking Cessation Interventions in Stroke Patients
The primary objective of the present randomized controlled trial is to compare the effectiveness of three anti-smoking interventions of different intensities.
- Trial name
- NCT01574001
- Testing
- Antismoking intervention with no early follow-up, Antismoking intervention with minimal early follow-up, Antismoking intervention with intensive early follow-up
- Where
- Poland
- Volunteers
- 240 people
- Sponsor
- Institute of Psychiatry and Neurology, Warsaw
Cancer Patients First-ever Acute Ischemic Stroke
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Patients with cancer who develop stroke are at high risk for future strokes or other clotting events. These patients are routinely treated with medicines that thin their blood, including enoxaparin or aspirin.
- Trial name
- NCT01763606
- Testing
- Enoxaparin, Aspirin
- Where
- 7 sites in United States
- Volunteers
- 20 people
- Sponsor
- Memorial Sloan Kettering Cancer Center
First Ever Clinical Stroke, Ischemic Stroke
Rehabilitation Combined With Bihemispherictranscranial Direct Current Stimulation in Subacute Ischemic Stroke
Rehabilitation after stroke improves motor functions by promoting plastic changes however, after completing standard rehabilitation, 50-60% of patients still exhibit some degree of motor impairment and require at least partial…
- Conditions
- First Ever Clinical Stroke, Ischemic Stroke, Subacute Phase, Persistent Hemiparesis of Upper Extremity
- Trial name
- RECOMBINE (NCT01644929)
- Testing
- transcranial direct current stimulation (tDCS)
- Where
- 3 sites in Switzerland
- Volunteers
- 36 people
- Sponsor
- Dr. med. Carlo Cereda